Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ORIFARM PI A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   2.3% 3.0% 1.8% 2.1% 2.3% 2.3% 11.4% 11.4%   Credit score (0-100)   66 57 71 66 63 65 21 21   Credit rating   BBB BBB A BBB BBB BBB BB BB   Credit limit (kDKK)   8.1 0.1 457.2 32.8 13.9 17.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -73.0 -57.0 -76.0 -73.0 -65.0 -58.0 0.0 0.0   EBITDA   -73.0 -57.0 -76.0 -73.0 -95.0 -88.0 0.0 0.0   EBIT   -73.0 -57.0 -76.0 -73.0 -95.0 -88.0 0.0 0.0   Pre-tax profit (PTP)   191,712.0 208,545.0 205,747.0 182,228.0 251,375.0 321,756.0 0.0 0.0   Net earnings   191,779.0 208,734.0 206,026.0 182,945.0 253,407.0 320,939.0 0.0 0.0   Pre-tax profit without non-rec. items   191,712 208,545 205,747 182,228 251,375 321,756 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   554,384 563,785 759,954 687,448 940,668 1,161,019 3,530 3,530   Interest-bearing liabilities   0.0 95,320 97,675 130,280 130,222 169,288 0.0 0.0   Balance sheet total (assets)   554,406 659,123 857,664 817,787 1,070,912 1,330,336 3,530 3,530   Net Debt   0.0 95,320 97,675 130,280 130,222 169,288 -3,530 -3,530     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -73.0 -57.0 -76.0 -73.0 -65.0 -58.0 0.0 0.0   Gross profit growth   57.1% 21.9% -33.3% 3.9% 11.0% 10.8% 0.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   554,406 659,123 857,664 817,787 1,070,912 1,330,336 3,530 3,530   Balance sheet change%   -1.1% 18.9% 30.1% -4.6% 31.0% 24.2% -99.7% 0.0%   Added value   -73.0 -57.0 -76.0 -73.0 -95.0 -88.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -4.0 -5.0 -5.0 -5.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 146.2% 151.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   34.5% 34.5% 27.5% 22.2% 27.7% 27.7% 0.0% 0.0%   ROI %   34.5% 34.5% 27.5% 22.2% 27.7% 27.7% 0.0% 0.0%   ROE %   36.3% 37.3% 31.1% 25.3% 31.1% 30.5% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   100.0% 85.5% 88.6% 84.1% 87.8% 87.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% -167,228.1% -128,519.7% -178,465.8% -137,075.8% -192,372.7% 0.0% 0.0%   Gearing %   0.0% 16.9% 12.9% 19.0% 13.8% 14.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.1% 1.9% 2.6% 3.2% 8.2% 7.3% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   553.7 0.0 2.6 0.0 0.0 0.0 0.0 0.0   Current Ratio   553.7 0.0 2.6 0.0 0.0 0.0 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 120.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   12,159.0 -95,149.0 152,569.0 -129,794.0 -128,178.0 -164,629.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0